ÂÜÀòÂÒÂ×

Greg Foley is currently the Associate Director at Kano Therapeutics, where Greg is focused on synthetic biology for cell and gene therapies. Prior to this, Greg has worked at various companies, including Colossal Biosciences, Joyn Bio, enEvolv, and Harvard Medical School, holding roles related to genome engineering, microbial engineering, and molecular and microbiology research. With a Bachelor's degree in Physical Anthropology and Environmental Science from Brandeis University, Greg has a strong background in environmental science and biology.